rs393548

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_005535.3(IL12RB1):​c.-111A>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.209 in 1,547,552 control chromosomes in the GnomAD database, including 34,726 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.21 ( 3496 hom., cov: 31)
Exomes 𝑓: 0.21 ( 31230 hom. )

Consequence

IL12RB1
NM_005535.3 5_prime_UTR

Scores

2
Splicing: ADA: 0.00006553
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -1.34

Publications

28 publications found
Variant links:
Genes affected
IL12RB1 (HGNC:5971): (interleukin 12 receptor subunit beta 1) The protein encoded by this gene is a type I transmembrane protein that belongs to the hemopoietin receptor superfamily. This protein binds to interleukine 12 (IL12) with a low affinity, and is thought to be a part of IL12 receptor complex. This protein forms a disulfide-linked oligomer, which is required for its IL12 binding activity. The coexpression of this and IL12RB2 proteins was shown to lead to the formation of high-affinity IL12 binding sites and reconstitution of IL12 dependent signaling. Mutations in this gene impair the development of interleukin-17-producing T lymphocytes and result in increased susceptibility to mycobacterial and Salmonella infections. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014]
IL12RB1 Gene-Disease associations (from GenCC):
  • Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 19-18086934-T-A is Benign according to our data. Variant chr19-18086934-T-A is described in ClinVar as Benign. ClinVar VariationId is 402972.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.243 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IL12RB1NM_005535.3 linkc.-111A>T 5_prime_UTR_variant Exon 1 of 17 ENST00000593993.7 NP_005526.1 P42701-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IL12RB1ENST00000593993.7 linkc.-111A>T 5_prime_UTR_variant Exon 1 of 17 1 NM_005535.3 ENSP00000472165.2 P42701-1

Frequencies

GnomAD3 genomes
AF:
0.212
AC:
32143
AN:
151432
Hom.:
3487
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.247
Gnomad AMI
AF:
0.138
Gnomad AMR
AF:
0.153
Gnomad ASJ
AF:
0.200
Gnomad EAS
AF:
0.154
Gnomad SAS
AF:
0.190
Gnomad FIN
AF:
0.229
Gnomad MID
AF:
0.127
Gnomad NFE
AF:
0.210
Gnomad OTH
AF:
0.207
GnomAD2 exomes
AF:
0.193
AC:
29266
AN:
151862
AF XY:
0.195
show subpopulations
Gnomad AFR exome
AF:
0.248
Gnomad AMR exome
AF:
0.135
Gnomad ASJ exome
AF:
0.209
Gnomad EAS exome
AF:
0.134
Gnomad FIN exome
AF:
0.221
Gnomad NFE exome
AF:
0.211
Gnomad OTH exome
AF:
0.178
GnomAD4 exome
AF:
0.209
AC:
291921
AN:
1396002
Hom.:
31230
Cov.:
32
AF XY:
0.209
AC XY:
143993
AN XY:
689156
show subpopulations
African (AFR)
AF:
0.247
AC:
7727
AN:
31248
American (AMR)
AF:
0.136
AC:
4784
AN:
35208
Ashkenazi Jewish (ASJ)
AF:
0.203
AC:
5099
AN:
25070
East Asian (EAS)
AF:
0.193
AC:
6931
AN:
35846
South Asian (SAS)
AF:
0.192
AC:
15243
AN:
79506
European-Finnish (FIN)
AF:
0.217
AC:
10269
AN:
47288
Middle Eastern (MID)
AF:
0.191
AC:
1084
AN:
5682
European-Non Finnish (NFE)
AF:
0.212
AC:
228993
AN:
1078274
Other (OTH)
AF:
0.204
AC:
11791
AN:
57880
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
10742
21484
32226
42968
53710
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8060
16120
24180
32240
40300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.212
AC:
32195
AN:
151550
Hom.:
3496
Cov.:
31
AF XY:
0.212
AC XY:
15731
AN XY:
74048
show subpopulations
African (AFR)
AF:
0.248
AC:
10214
AN:
41268
American (AMR)
AF:
0.152
AC:
2322
AN:
15242
Ashkenazi Jewish (ASJ)
AF:
0.200
AC:
692
AN:
3466
East Asian (EAS)
AF:
0.154
AC:
798
AN:
5168
South Asian (SAS)
AF:
0.191
AC:
921
AN:
4816
European-Finnish (FIN)
AF:
0.229
AC:
2392
AN:
10430
Middle Eastern (MID)
AF:
0.137
AC:
40
AN:
292
European-Non Finnish (NFE)
AF:
0.210
AC:
14251
AN:
67858
Other (OTH)
AF:
0.209
AC:
439
AN:
2098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1318
2635
3953
5270
6588
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
342
684
1026
1368
1710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.215
Hom.:
680
Bravo
AF:
0.203
Asia WGS
AF:
0.195
AC:
681
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 32% of patients studied by a panel of primary immunodeficiencies. Number of patients: 28. Only high quality variants are reported. -

Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
5.5
DANN
Benign
0.54
PhyloP100
-1.3
PromoterAI
-0.074
Neutral
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000066
dbscSNV1_RF
Benign
0.0060
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs393548; hg19: chr19-18197744; COSMIC: COSV59096451; COSMIC: COSV59096451; API